Erratum: Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib (Blood Advances (2017) 1: 26 (2610-2623) DOI: 10.1182/bloodadvances.2017011999)

Abstract

In "Acknowledgments" on page 2621 of the 12 December 2017 issue, funding from British Heart Foundation grant RG/15/2/31224 was not mentioned. The error has been corrected in the published article